David Sinclair, a professor at Harvard Medical School, has said that he thinks the first person who will live to the age of 150 is already alive today.
asserted
who → say → 150
During a panel discussion about longevity at the TIME100 Health Leadership Forum in New York City on Sept. 10, TIME executive editor Nikhil Kumar asked Sinclair what motivated him to say that.
asserted
what → ask → that
“Children born today will live into the 22nd century, and just think about in the last five years what’s happened to our world; it’s barely recognizable when it comes to AI and even the healthcare world,” Sinclair replied.
asserted
Sinclair → bear → AI
“So, in the 22nd century, children born today are going to have access to technologies that we literally cannot even imagine now.”
asserted
we → bear → that
Sinclair was joined on stage by Jennifer Garrison, a neuroscientist with expertise in the women’s health biotech field, and Jack Jia, the founder and CEO of Musely, a telehealth platform aimed at expanding access to personalized prescription care that sponsored the event on Sept. 10.
asserted
that → join → Sept.
Garrison’s longevity work focuses largely on women’s health, in particular on ovaries—something she said affects not just women, but everyone, because “understanding the differences between male bodies and female bodies gives us levers with which to develop medicines.”
asserted
understanding → focus → medicines
“When we miss female physiology, we’ve essentially left out half of the picture,” she said.
asserted
she → miss → picture
For example, she said, female bodies tend to be better at fighting viruses than male bodies.
asserted
bodies → say → bodies
Researchers don’t fully understand why, but if they were able to understand those differences, it could help better equip the medical community to treat everyone depending on their needs, Garrison argued.
uncertain
Garrison → understand → needs
When Kumar asked her how far along the medical field is in understanding these differences, Garrison replied, “We’re pretty far behind, as it turns out.”
asserted
it → ask → differences
But, she continued, “Everyone understands that there’s a challenge here that we’ve got a data gap, that we’ve got this systemic bias about our research, that we’re essentially, I think, generations behind.”
asserted
I → continue → research
“It’s not years.
asserted
It → ’ → ?
It’s not decades.
asserted
It → ’ → ?
It’s generations behind in terms of the data,” she said.
asserted
she → ’ → data
“So we’re catching up, but it’s going to take a while.”
asserted
it → catch → while
During the conversation, Jia shared that he was inspired to expand Musely beyond being a skincare tip platform after his wife’s struggle to find effective treatments for her melasma.
asserted
he → share → melasma
“This kind of wellness or cosmetics conditions are everyone’s problem,” Jia said.
asserted
Jia → say → conditions
But “the entire healthcare system is not designed to solve that problem; it’s designed to solve that real sick person who is dying.”
asserted
who → design → person
Since then, Jia has broadened Musely’s scope to include resources and treatments for proactive health and longevity.
asserted
Jia → broaden → health
Kumar went on to ask the panelists what they think about the recent “explosion in testing” in the longevity space—how people are getting all kinds of tests and scans to, they claim, optimize living longer and better.
uncertain
they → go → tests
Garrison said that, where there is evidence for the test, it’s a great option.
asserted
it → say → test
“I think we can all acknowledge that there’s a little bit of a credibility issue in the longevity space, and a lot of the products that are marketed are either poorly supported by evidence or outright pseudoscience,” Garrison said.
asserted
Garrison → think → evidence
“For women, the amount of information and marketing that comes at us these days is crazy.
asserted
that → come → us
And part of the problem is that it’s very hard as a consumer, as someone who’s not a scientist or a doctor, to really make the call between, ‘Is this real or not?’”
asserted
this → ’ → call
Sinclair expressed concerns that what people used to consider to be “fringe” behaviors, such as injecting oneself with peptides or taking drugs that have not yet been proven to be effective in humans, is becoming more common.
asserted
that → express → humans
“I wonder where we’re going to go,” he said.
asserted
he → wonder → ?
“But I do applaud the fact that people do have the right, with their doctors … to try something if there’s nothing else that works, and there’s no seemingly bad downside.”
asserted
that → applaud → something
“I thought that five years ago, in my opinion, the regulations were so strict that even people who were suffering or dying couldn’t get medicines,” he continued.
asserted
he → think → medicines
“That was too extreme in my view, but we’ve gone with the other extreme.”
asserted
we → go → extreme
The TIME100 Health Leadership Forum was presented by the American Cancer Society, Kite—a Gilead Sciences company, Insulet, Musely, and NMDP.
asserted
Forum → present → Society
The Aporia
.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9)
